pharmacopeia

药典
  • 文章类型: Journal Article
    背景:因特定疾病住院的患者可能正在接受其他当代疾病或合并症的其他治疗。在新出现的疾病的背景下,使用这种观察性临床数据进行药理学假设的产生是有吸引力的,但由于存在药物适应症偏倚,因此特别具有挑战性。
    目的:通过这项研究,我们的主要目标是开发和验证完全数据驱动的管道,以应对这一挑战.我们的次要目标是在COVID-19患者中产生药理学假设,并证明该管道的临床相关性。
    方法:我们开发了一个药典范围的关联研究(PheWAS)管道,灵感来自PheWAS方法,系统筛选整个药典和临床表型之间的关联。首先,基于自适应最小绝对收缩和选择操作员(LASSO)确定的药物特定调整集的完全数据驱动程序。第二,我们计算了几种关联度量,包括基于倾向评分(PS)的稳健方法来控制指示偏差。最后,我们应用了错误发现率(FDR)的Benjamini和Hochberg程序。我们使用大巴黎地区16家大学医院的电子病历,将此方法应用于多中心回顾性队列研究中。我们纳入了2020年2月1日至2021年6月15日在常规病房因COVID-19住院的所有18至95岁的成年患者。我们调查了入院后48小时内的药物处方与28天死亡率之间的关系。我们验证了我们的数据驱动管道与基于知识的管道在3种参考处理,对此,专家就预期与死亡率的相关性达成了一致。然后,我们通过筛选100多名患者的所有处方药物以产生药理学假设来证明其临床意义。
    结果:总共5783例患者被纳入分析。入院时的平均年龄为69.2岁(IQR56.7-81.1),3390例(58.62%)患者为男性。在控制偏差方面,我们的自动化管道的性能与3种参考药物的基于知识的调整集相当或更好:地塞米松,间苯三酚,和扑热息痛.校正多次测试后,4种药物与住院死亡率增加相关。其中,地西泮和曲马多是唯一没有被自动诊断丢弃的药物,调整后的赔率比为2.51(95%CI1.52-4.16,Q=.1)和1.94(95%CI1.32-2.85,Q=.02),分别。
    结论:我们的创新方法被证明可用于在爆发环境中产生药理学假设,不需要疾病的先验知识。我们对COVID-19住院患者的早期处方治疗的系统分析表明,地西泮和曲马多与28天死亡率增加有关。这些药物是否会使COVID-19恶化,需要进一步评估。
    BACKGROUND: Patients hospitalized for a given condition may be receiving other treatments for other contemporary conditions or comorbidities. The use of such observational clinical data for pharmacological hypothesis generation is appealing in the context of an emerging disease but particularly challenging due to the presence of drug indication bias.
    OBJECTIVE: With this study, our main objective was the development and validation of a fully data-driven pipeline that would address this challenge. Our secondary objective was to generate pharmacological hypotheses in patients with COVID-19 and demonstrate the clinical relevance of the pipeline.
    METHODS: We developed a pharmacopeia-wide association study (PharmWAS) pipeline inspired from the PheWAS methodology, which systematically screens for associations between the whole pharmacopeia and a clinical phenotype. First, a fully data-driven procedure based on adaptive least absolute shrinkage and selection operator (LASSO) determined drug-specific adjustment sets. Second, we computed several measures of association, including robust methods based on propensity scores (PSs) to control indication bias. Finally, we applied the Benjamini and Hochberg procedure of the false discovery rate (FDR). We applied this method in a multicenter retrospective cohort study using electronic medical records from 16 university hospitals of the Greater Paris area. We included all adult patients between 18 and 95 years old hospitalized in conventional wards for COVID-19 between February 1, 2020, and June 15, 2021. We investigated the association between drug prescription within 48 hours from admission and 28-day mortality. We validated our data-driven pipeline against a knowledge-based pipeline on 3 treatments of reference, for which experts agreed on the expected association with mortality. We then demonstrated its clinical relevance by screening all drugs prescribed in more than 100 patients to generate pharmacological hypotheses.
    RESULTS: A total of 5783 patients were included in the analysis. The median age at admission was 69.2 (IQR 56.7-81.1) years, and 3390 (58.62%) of the patients were male. The performance of our automated pipeline was comparable or better for controlling bias than the knowledge-based adjustment set for 3 reference drugs: dexamethasone, phloroglucinol, and paracetamol. After correction for multiple testing, 4 drugs were associated with increased in-hospital mortality. Among these, diazepam and tramadol were the only ones not discarded by automated diagnostics, with adjusted odds ratios of 2.51 (95% CI 1.52-4.16, Q=.1) and 1.94 (95% CI 1.32-2.85, Q=.02), respectively.
    CONCLUSIONS: Our innovative approach proved useful in generating pharmacological hypotheses in an outbreak setting, without requiring a priori knowledge of the disease. Our systematic analysis of early prescribed treatments from patients hospitalized for COVID-19 showed that diazepam and tramadol are associated with increased 28-day mortality. Whether these drugs could worsen COVID-19 needs to be further assessed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    BACKGROUND: Assessing the effectiveness of in-service training courses in order to achieve the desired goals and reduce the waste of costs and opportunities in the system is necessary. The purpose of this study was to determine the effectiveness of the \"pharmacopeia home health\" course considering its importance in different aspects using the Kirkpatrick model.
    METHODS: The present study was a quasi-experimental conducted at community health workers (CHWs) on three levels of reaction, learning, and behavior. In each phase, a valid questionnaire was used to measure the outcome according to the Ministry of Health guidelines with pretest and posttest measurements. The data were analyzed through SPSS 23, using descriptive statistics and repeated measures test and general linear model.
    RESULTS: The results of the study showed that at the level of reaction in terms of content and holding, conditions of implementation were favorable. Findings at the level of learning showed that the training course was only effective in enhancing the knowledge and awareness about drug maintenance and had no significant effect on other areas. In the third level, the results of the CHWs\' performance showed that in some areas, the results were influenced by the demographic variables.
    CONCLUSIONS: The present study showed the effectiveness of education in different areas using on the Kirkpatrick model. Given the lack of impact of education in some areas in the present study and on the other, it is necessary to consider cooperative learning methods in order to develop the effectiveness of the courses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • DOI:
    文章类型: Journal Article
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号